<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Interference of <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> (aPL) with coagulation was investigated in 40 aPL-patients (24 with <z:mp ids='MP_0005048'>thrombosis</z:mp>) using thrombography </plain></SENT>
<SENT sid="1" pm="."><plain>Impairment of the activated protein C <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> pathway was partially offset by the genuine <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> effect </plain></SENT>
<SENT sid="2" pm="."><plain>The net result, a procoagulant phenotype, was associated with a 7-fold increased risk of <z:mp ids='MP_0005048'>thrombosis</z:mp> in aPL-patients </plain></SENT>
</text></document>